Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (46.160)

11

Crystal structures of human CD40 in complex with monoclonal antibodies dacetuzumab and bleselumab

enthalten in: Biochemical and biophysical research communications | 2024

von Asano, R. | Nakakido, M. | Pérez, J. | +4

12

A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors : A children's oncology group consortium report (ADVL1614)

enthalten in: Pediatric blood & cancer | 2024

von Greengard, E. | Williams, R. | Moriarity, B. | +10

13

Dupilumab induced ocular surface disease : A prospective case series

enthalten in: European journal of ophthalmology | 2024

von Pradhan, S. | Sadiq, S. | Cartes, C. | +5

14

Efficacy and safety analysis of Dupilumab for atopic dermatitis of all ages in Chinese population : Real-world data from a single center

enthalten in: Allergy | 2024

von Yang, Z. | Wen, W. | Shi, R. | +6

15

Role of Teplizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Managing Newly Diagnosed Type 1 Diabetes : An Updated Systematic Review and Meta-Analysis

enthalten in: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists | 2024

von Kamrul-Hasan, A. | Mondal, S. | Nagendra, L. | +3

16

Therapeutic plasma exchange as an intervention for gemtuzumab ozogamicin impaired hemoglobin scavenging : A case and systematic review

enthalten in: Journal of clinical apheresis | 2024

von Adkins, B. | Noland, D. | Slone, T. | +1

17

Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP

enthalten in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery | 2024

von Rosso, C. | De Corso, E. | Conti, V. | +11

18

Sarilumab (Kevzara) for polymyalgia rheumatica

enthalten in: The Medical letter on drugs and therapeutics | 2024

19

Efficacy and safety of eptinezumab 300mg versus 100mg for migraine patients : a meta-analysis of randomized controlled studies

enthalten in: The International journal of neuroscience | 2024

von Chen, H. | Luo, W.

20

Tocilizumab Versus Baricitinib for the Treatment of COVID-19 in Patients With Obesity

enthalten in: Journal of pharmacy practice | 2024

von Troyer, B. | Kovacic Scherrer, N. | Garavaglia, J.